US Stock MarketDetailed Quotes

EIGRQ Eiger BioPharmaceuticals

Watchlist

11.290
+0.090+0.80%

15min DelayClose Jul 5 16:00 ET

16.72MMarket Cap-222P/E (TTM)

Eiger BioPharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

10.19%-74.55M

37.28%-13.95M

29.21%-14.55M

-1.34%-22.04M

-30.04%-24.01M

-16.36%-83.01M

-32.70%-22.25M

-6.75%-20.56M

-6.67%-21.74M

-23.61%-18.46M

Net income from continuing operations

22.54%-74.96M

46.48%-13.45M

33.50%-18.03M

5.43%-20.7M

-0.62%-22.78M

-185.33%-96.78M

-15.48%-25.14M

-22.00%-27.11M

-14.13%-21.88M

-177.42%-22.64M

Operating gains losses

----

102.46%1.14M

--0

----

Depreciation and amortization

-10.93%750K

-16.67%180K

-6.60%198K

-12.44%183K

-7.80%189K

5.38%842K

9.64%216K

9.28%212K

-2.34%209K

5.67%205K

Other non cash items

18.85%1.49M

3.77%385K

-3.51%385K

34.33%360K

66.21%364K

76.30%1.26M

48.40%371K

56.47%399K

13.08%268K

855.17%219K

Change In working capital

-1,291.89%-5.73M

-449.79%-1.68M

-16.49%2.12M

43.31%-2.22M

-385.76%-3.95M

135.87%481K

-78.70%480K

2,271.79%2.54M

-0.98%-3.92M

239.80%1.38M

-Change in receivables

-89.86%84K

-147.46%-337K

267.61%2.38M

-86.31%171K

-837.02%-2.13M

132.14%828K

281.72%710K

-7.25%-1.42M

256.32%1.25M

145.23%289K

-Change in inventory

218.95%1.63M

-34.11%-637K

-61.57%-908K

504.72%4.03M

-229.13%-860K

43.61%-1.37M

-556.73%-475K

-1.08%-562K

-49.10%-996K

151.07%666K

-Change in prepaid assets

2,227.04%4.17M

88.66%3.75M

-307.91%-946K

98.26%-31K

264.05%1.4M

72.04%-196K

266.25%1.99M

198.06%455K

-211.54%-1.78M

-155.85%-854K

-Change in payables and accrued expense

-517.50%-12.98M

-352.59%-4.2M

-80.45%836K

-235.44%-6.94M

-246.47%-2.68M

-43.91%3.11M

-130.25%-928K

41.45%4.28M

-36.23%-2.07M

88.56%1.83M

-Change in other current assets

246.80%1.86M

79.97%-130K

1,927.08%877K

483.63%656K

214.36%454K

-108.40%-1.27M

-382.17%-649K

92.67%-48K

-4.27%-171K

-2,105.56%-397K

-Change in other current liabilities

22.13%-489K

26.38%-120K

26.88%-117K

26.45%-114K

8.00%-138K

-9.03%-628K

-16.43%-163K

-13.48%-160K

5.49%-155K

-14.50%-150K

Cash from discontinued investing activities

Operating cash flow

10.19%-74.55M

37.28%-13.95M

29.21%-14.55M

-1.34%-22.04M

-30.04%-24.01M

-16.36%-83.01M

-32.70%-22.25M

-6.75%-20.56M

-6.67%-21.74M

-23.61%-18.46M

Investing cash flow

Cash flow from continuing investing activities

670.64%74.23M

-44.95%12M

82.97%19M

252.69%29.85M

545.80%13.38M

-84.35%9.63M

263.48%21.8M

214.76%10.38M

14.63%-19.55M

-103.18%-3M

Net PPE purchase and sale

31.18%-234K

99.55%-1K

--0

-88.89%-17K

---216K

-51.11%-340K

-68.42%-224K

---107K

88.16%-9K

--0

Net investment purchase and sale

646.71%74.46M

-45.51%12M

81.11%19M

252.85%29.86M

553.00%13.6M

-33.44%9.97M

266.83%22.02M

218.01%10.49M

14.39%-19.54M

-106.29%-3M

Cash from discontinued investing activities

Investing cash flow

670.64%74.23M

-44.95%12M

82.97%19M

252.69%29.85M

545.80%13.38M

-84.35%9.63M

263.48%21.8M

214.76%10.38M

14.63%-19.55M

-103.18%-3M

Financing cash flow

Cash flow from continuing financing activities

-99.95%41K

111.67%7K

117.05%15K

-100.07%-22K

-99.91%41K

2,329.90%76.96M

-101.96%-60K

-155.00%-88K

43,573.61%31.3M

305,246.67%45.8M

Net issuance payments of debt

--0

----

--6.56M

--1K

--0

----

Net common stock issuance

--0

2,248.75%71.4M

--0

--25.79M

--45.61M

Proceeds from stock option exercised by employees

-85.68%56K

--0

-88.55%15K

--0

-80.29%41K

-36.73%391K

-67.42%43K

-28.80%131K

190.00%9K

-33.33%208K

Net other financing activities

98.93%-15K

106.73%7K

--0

----

-185.54%-1.4M

3.70%-104K

-812.50%-219K

-1,614.52%-1.06M

94.61%-16K

Cash from discontinued financing activities

Financing cash flow

-99.95%41K

111.67%7K

117.05%15K

-100.07%-22K

-99.91%41K

2,329.90%76.96M

-101.96%-60K

-155.00%-88K

43,573.61%31.3M

305,246.67%45.8M

Net cash flow

Beginning cash position

16.10%25.8M

4.53%27.5M

-37.16%22.98M

-67.40%15.18M

16.10%25.8M

-23.01%22.22M

-46.59%26.31M

-43.78%36.57M

-57.05%46.56M

-23.01%22.22M

Current changes in cash

-107.80%-279K

-281.96%-1.95M

143.46%4.46M

177.97%7.79M

-143.47%-10.58M

153.85%3.58M

98.11%-510K

35.04%-10.26M

76.96%-9.99M

-69.40%24.34M

Effect of exchange rate changes

---79K

---113K

--57K

--13K

---36K

--0

End cash Position

-1.39%25.44M

4.53%27.5M

-37.16%22.98M

-67.40%15.18M

16.10%25.8M

-46.59%26.31M

-43.78%36.57M

-57.05%46.56M

Free cash flow

10.28%-74.78M

37.90%-13.96M

29.58%-14.55M

-1.37%-22.05M

-31.22%-24.22M

30.58%-83.35M

-32.98%-22.47M

-7.31%-20.67M

-6.32%-21.75M

70.91%-18.46M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	10.19%-74.55M	37.28%-13.95M	29.21%-14.55M	-1.34%-22.04M	-30.04%-24.01M	-16.36%-83.01M	-32.70%-22.25M	-6.75%-20.56M	-6.67%-21.74M	-23.61%-18.46M
Net income from continuing operations	22.54%-74.96M	46.48%-13.45M	33.50%-18.03M	5.43%-20.7M	-0.62%-22.78M	-185.33%-96.78M	-15.48%-25.14M	-22.00%-27.11M	-14.13%-21.88M	-177.42%-22.64M
Operating gains losses	----	----	----	----	----	102.46%1.14M	--0	--0	----	----
Depreciation and amortization	-10.93%750K	-16.67%180K	-6.60%198K	-12.44%183K	-7.80%189K	5.38%842K	9.64%216K	9.28%212K	-2.34%209K	5.67%205K
Other non cash items	18.85%1.49M	3.77%385K	-3.51%385K	34.33%360K	66.21%364K	76.30%1.26M	48.40%371K	56.47%399K	13.08%268K	855.17%219K
Change In working capital	-1,291.89%-5.73M	-449.79%-1.68M	-16.49%2.12M	43.31%-2.22M	-385.76%-3.95M	135.87%481K	-78.70%480K	2,271.79%2.54M	-0.98%-3.92M	239.80%1.38M
-Change in receivables	-89.86%84K	-147.46%-337K	267.61%2.38M	-86.31%171K	-837.02%-2.13M	132.14%828K	281.72%710K	-7.25%-1.42M	256.32%1.25M	145.23%289K
-Change in inventory	218.95%1.63M	-34.11%-637K	-61.57%-908K	504.72%4.03M	-229.13%-860K	43.61%-1.37M	-556.73%-475K	-1.08%-562K	-49.10%-996K	151.07%666K
-Change in prepaid assets	2,227.04%4.17M	88.66%3.75M	-307.91%-946K	98.26%-31K	264.05%1.4M	72.04%-196K	266.25%1.99M	198.06%455K	-211.54%-1.78M	-155.85%-854K
-Change in payables and accrued expense	-517.50%-12.98M	-352.59%-4.2M	-80.45%836K	-235.44%-6.94M	-246.47%-2.68M	-43.91%3.11M	-130.25%-928K	41.45%4.28M	-36.23%-2.07M	88.56%1.83M
-Change in other current assets	246.80%1.86M	79.97%-130K	1,927.08%877K	483.63%656K	214.36%454K	-108.40%-1.27M	-382.17%-649K	92.67%-48K	-4.27%-171K	-2,105.56%-397K
-Change in other current liabilities	22.13%-489K	26.38%-120K	26.88%-117K	26.45%-114K	8.00%-138K	-9.03%-628K	-16.43%-163K	-13.48%-160K	5.49%-155K	-14.50%-150K
Cash from discontinued investing activities
Operating cash flow	10.19%-74.55M	37.28%-13.95M	29.21%-14.55M	-1.34%-22.04M	-30.04%-24.01M	-16.36%-83.01M	-32.70%-22.25M	-6.75%-20.56M	-6.67%-21.74M	-23.61%-18.46M
Investing cash flow
Cash flow from continuing investing activities	670.64%74.23M	-44.95%12M	82.97%19M	252.69%29.85M	545.80%13.38M	-84.35%9.63M	263.48%21.8M	214.76%10.38M	14.63%-19.55M	-103.18%-3M
Net PPE purchase and sale	31.18%-234K	99.55%-1K	--0	-88.89%-17K	---216K	-51.11%-340K	-68.42%-224K	---107K	88.16%-9K	--0
Net investment purchase and sale	646.71%74.46M	-45.51%12M	81.11%19M	252.85%29.86M	553.00%13.6M	-33.44%9.97M	266.83%22.02M	218.01%10.49M	14.39%-19.54M	-106.29%-3M
Cash from discontinued investing activities
Investing cash flow	670.64%74.23M	-44.95%12M	82.97%19M	252.69%29.85M	545.80%13.38M	-84.35%9.63M	263.48%21.8M	214.76%10.38M	14.63%-19.55M	-103.18%-3M
Financing cash flow
Cash flow from continuing financing activities	-99.95%41K	111.67%7K	117.05%15K	-100.07%-22K	-99.91%41K	2,329.90%76.96M	-101.96%-60K	-155.00%-88K	43,573.61%31.3M	305,246.67%45.8M
Net issuance payments of debt	--0	--0	--0	----	----	--6.56M	--1K	--0	----	----
Net common stock issuance	--0	--0	--0	--0	--0	2,248.75%71.4M	--0	--0	--25.79M	--45.61M
Proceeds from stock option exercised by employees	-85.68%56K	--0	-88.55%15K	--0	-80.29%41K	-36.73%391K	-67.42%43K	-28.80%131K	190.00%9K	-33.33%208K
Net other financing activities	98.93%-15K	106.73%7K	--0	----	----	-185.54%-1.4M	3.70%-104K	-812.50%-219K	-1,614.52%-1.06M	94.61%-16K
Cash from discontinued financing activities
Financing cash flow	-99.95%41K	111.67%7K	117.05%15K	-100.07%-22K	-99.91%41K	2,329.90%76.96M	-101.96%-60K	-155.00%-88K	43,573.61%31.3M	305,246.67%45.8M
Net cash flow
Beginning cash position	16.10%25.8M	4.53%27.5M	-37.16%22.98M	-67.40%15.18M	16.10%25.8M	-23.01%22.22M	-46.59%26.31M	-43.78%36.57M	-57.05%46.56M	-23.01%22.22M
Current changes in cash	-107.80%-279K	-281.96%-1.95M	143.46%4.46M	177.97%7.79M	-143.47%-10.58M	153.85%3.58M	98.11%-510K	35.04%-10.26M	76.96%-9.99M	-69.40%24.34M
Effect of exchange rate changes	---79K	---113K	--57K	--13K	---36K	--0	--0	--0	--0	--0
End cash Position	-1.39%25.44M	-1.39%25.44M	4.53%27.5M	-37.16%22.98M	-67.40%15.18M	16.10%25.8M	16.10%25.8M	-46.59%26.31M	-43.78%36.57M	-57.05%46.56M
Free cash flow	10.28%-74.78M	37.90%-13.96M	29.58%-14.55M	-1.37%-22.05M	-31.22%-24.22M	30.58%-83.35M	-32.98%-22.47M	-7.31%-20.67M	-6.32%-21.75M	70.91%-18.46M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall